Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 178, pseudogene (RN7SL178P)

Target
RN7SL178P
Molecular classification
Non-coding RNA pseudogene
01

Overview

**RN7SL178P** is a pseudogene derived from sequences related to **7SL RNA**, the central RNA component of the signal recognition particle (SRP)[2][4]. The SRP is essential for cotranslational targeting of secretory proteins to the endoplasmic reticulum in eukaryotic cells[3][1][5]. The human genome contains hundreds of 7SL RNA-like sequences, most of which are pseudogenes formed by reverse transcription and genomic insertion of truncated or mutated 7SL RNA transcripts. These pseudogenes do not produce functional RNA and do not participate in the SRP role[4]. Unlike functional RNAs such as **RN7SL1**, which are essential for protein targeting and have been implicated in disease contexts (cancer, neuroinflammation, antiviral defense)[1][5], **RN7SL178P** is structurally related but classified as a **pseudogene**, meaning it lacks biological function, is not a therapeutic target, and has no known role in pathogenesis or pharmacology[2][4]. These pseudogenes are mainly used to study genomic evolution, transposable elements (Alu family origins)[3], and molecular taxonomy.

Other names
RN7SL178P7SL pseudogeneRNA, 7SL, cytoplasmic 178, pseudogene
02

Mechanism of action

None reported

03

Biological functions

None (pseudogene; typically not expressed/functional)
04

Disease associations

None directly attributed (see below for context)
05

Safety considerations

None reported
06

Interacting drugs

None reported
07

Biomarkers

None reported

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 178, pseudogene (RN7SL178P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 178, pseudogene (RN7SL178P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call